methylselenic acid has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Das, A; Mastro, AM; Prabhu, KS | 1 |
| Cao, S; Chintala, S; Durrani, FA; Najrana, T; Pili, R; Rustum, YM; Toth, K | 1 |
2 other study(ies) available for methylselenic acid and Cancer of Kidney
| Article | Year |
|---|---|
Dietary selenium supplementation modifies breast tumor growth and metastasis.
Topics: Animals; Blotting, Western; Bone Neoplasms; Dietary Supplements; Female; Flow Cytometry; Interferon-gamma; Interleukin-2; Interleukin-6; Kidney Neoplasms; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Organoselenium Compounds; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selenomethionine; Sodium Selenite; Tumor Cells, Cultured | 2013 |
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Dioxygenases; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Kidney Neoplasms; Mice; Mice, Nude; Organoselenium Compounds; Procollagen-Proline Dioxygenase; Protein Processing, Post-Translational; Proteolysis; Vascular Endothelial Growth Factor A; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays | 2012 |